Primary Site >> Liver Cancer

Gene >> CPQ

Journal: World J Gastroenterol. 2005 Jul 14;11(26):3980-4.
Title: Antitumor efficacy of lidamycin on hepatoma and active moiety of its molecule.
Author: Huang, Yun-Hong|Shang, Bo-Yang|Zhen, Yong-Su
PMID: 15996019
Journal: Anticancer Drugs. 2007 Feb;18(2):127-37.
Title: An enediyne-energized single-domain antibody-containing fusion protein shows potent antitumor activity.
Author: Miao, Qing-fang|Liu, Xiao-yun|Shang, Bo-yang|Ouyang, Zhi-gang|Zhen, Yong-su
PMID: 17159599
Journal: Sci China C Life Sci. 2007 Aug;50(4):447-56.
Title: Generation and antitumor effects of an engineered and energized fusion protein VL-LDP-AE composed of single-domain antibody and lidamycin.
Author: Miao, QingFang|Shang, BoYang|Ouyang, ZhiGang|Liu, XiaoYun|Zhen, YongSu
PMID: 17653664
Journal: Cancer Biother Radiopharm. 2012 Aug;27(6):384-91.
Title: Factor VII light chain-targeted lidamycin shows intensified therapeutic efficacy for liver cancer.
Author: Zhang, Qing|Liu, Xiujun|Xu, Shuangshuang|Li, Caihong|Zhang, Yang|Yang, Jie|Zheng, Junnian
PMID: 22651685
Journal: Oncol Rep. 2012 Oct;28(4):1193-9.
Title: Antitumor activities of dFv-LDP-AE: An enediyne-energized fusion protein targeting tumor-associated antigen gelatinases.
Author: Zhong, Gen-Shen|Wu, Min-Na|Guo, Xiao-Fang|Zhang, Sheng-Hua|Miao, Qing-Fang|Zhen, Yong-Su
PMID: 22797730
Journal: Eur J Pharm Sci. 2012 Nov 20;47(4):781-9.
Title: A cell penetrating peptide-integrated and enediyne-energized fusion protein shows potent antitumor activity.
Author: Ru, Qin|Shang, Bo-Yang|Miao, Qing-Fang|Li, Liang|Wu, Shu-Ying|Gao, Rui-Juan|Zhen, Yong-Su
PMID: 22982402
Journal: Biomed Pharmacother. 2013 Mar;67(2):164-71.
Title: An NGR-integrated and enediyne-energized apoprotein shows CD13-targeting antitumor activity.
Author: Zheng, Yan-Bo|Shang, Bo-Yang|Li, Yi|Zhen, Yong-Su
PMID: 23206754
Journal: Basic Clin Pharmacol Toxicol. 2015 Aug;117(2):105-16.
Title: A Gelatinases-targeting scFv-based Fusion Protein Shows Enhanced Antitumour Activity with Endostar against Hepatoma.
Author: Gao, Ruijuan|Li, Liang|Shang, Boyang|Zhao, Chunyan|Sheng, Weijin|Li, Diandong
PMID: 25615234
Journal: Oncotarget. 2016 Nov 29;7(48):79774-79786.
Title: Plasma glutamate carboxypeptidase is a negative regulator in liver cancer metastasis.
Author: Lee, Jae-Hye|Cho, Hyun-Soo|Lee, Jeong-Ju|Jun, Soo Young|Ahn, Jun-Ho|Min, Ju-Sik|Yoon, Ji-Yong|Choi, Min-Hyuk|Jeon, Su-Jin|Lim, Jung Hwa|Jung, Cho-Rok|Kim, Dae-Soo|Kim, Hyun-Taek|Factor, Valentina M|Lee, Yun-Han|Thorgeirsson, Snorri S|Kim, Cheol-Hee|Kim, N
PMID: 27806330
Journal: Mol Carcinog. 2017 May;56(5):1395-1404.
Title: A CD13-targeting peptide integrated protein inhibits human liver cancer growth by killing cancer stem cells and suppressing angiogenesis.
Author: Zheng, Yan-Bo|Gong, Jian-Hua|Liu, Xiu-Jun|Li, Yi|Zhen, Yong-Su
PMID: 27991698